100 Ouellette Avenue 13th Floor Windsor, Ontario N9A 6T3
519-258-6490 800-663-1145
(coming soon)
For free answers to your questions about the Advair lawsuit, please complete our online contact form.
August 9, 2004—GlaxoSmithKline Plc's asthma drugs Serevent and Advair will carry new warnings about a small risk of life-threatening asthma episodes or asthma-related deaths, the Food and Drug Administration said Thursday.
Full Article
